These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16525649)
1. Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells. Murad H; Collet P; Huin-Schohn C; Al-Makdissy N; Kerjan G; Chedotal A; Donner M; Devignes MD; Becuwe P; Schohn H; Domenjoud L; Dauça M Int J Oncol; 2006 Apr; 28(4):977-84. PubMed ID: 16525649 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719 [TBL] [Abstract][Full Text] [Related]
3. Regulation of aromatase by nuclear receptors. Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224 [TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550 [TBL] [Abstract][Full Text] [Related]
5. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro. Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322 [TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836 [TBL] [Abstract][Full Text] [Related]
7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1. Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107 [TBL] [Abstract][Full Text] [Related]
9. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018 [TBL] [Abstract][Full Text] [Related]
10. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488 [TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway. Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612 [TBL] [Abstract][Full Text] [Related]
13. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions. Mehta RG; Williamson E; Patel MK; Koeffler HP J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072 [TBL] [Abstract][Full Text] [Related]
14. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development. Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867 [TBL] [Abstract][Full Text] [Related]
15. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone. Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274 [TBL] [Abstract][Full Text] [Related]
17. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527 [TBL] [Abstract][Full Text] [Related]
18. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation. Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905 [TBL] [Abstract][Full Text] [Related]
19. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. Pandhare J; Cooper SK; Phang JM J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758 [TBL] [Abstract][Full Text] [Related]